Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Piqray 50 mg film-coated tablets Piqray 200 mg film-coated tablets EU/1/20/1455/004-006

Alpelisib

Novartis Europharm Limited

—

Pluvicto 1000 MBq/mL solution for injection/infusion EU/1/22/1703/001

Lutetium (177Lu) vipivotide tetraxetan

Novartis Europharm Limited

—

Revolade 12.5 mg film-coated tablets EU/1/10/612/010-012

Eltrombopag olamine

Novartis Europharm Limited

—

Revolade 25 mg film-coated tablets EU/1/10/612/1-3

Eltrombopag olamine

Novartis Europharm Limited

—

Revolade 25 mg powder for oral suspension EU/1/10/612/013

Eltrombopag olamine

Novartis Europharm Limited

—

Revolade 50 mg film-coated tablets EU/1/10/612/4-6

Eltrombopag olamine

Novartis Europharm Limited

—

Revolade 75 mg film-coated tablets EU/1/10/612/007-009

Eltrombopag (sb-497115)

Novartis Europharm Limited

—

Rhapsido 25 mg film-coated tablets EU/1/26/2024/001-003

Remibrutinib

Novartis Europharm Limited

—

Rydapt 25 mg soft capsules EU/1/17/1218/001

Midostaurin

Novartis Europharm Limited

—

Sandimmun 50 mg/ml Concentrate for Solution for Infusion PA0896/027/002

Ciclosporin

Novartis Ireland Limited

Marketed

SANDOSTATIN 100 microgram/1ml, solution for injection/infusion PA0896/028/002

Octreotide

Novartis Ireland Limited

Marketed

SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion PA0896/028/001

Octreotide

Novartis Ireland Limited

Marketed

SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003

Octreotide

Novartis Ireland Limited

Marketed

Sandostatin LAR 10 mg powder and solvent for suspension for injection PA0896/028/004

Octreotide

Novartis Ireland Limited

Marketed

Sandostatin LAR 20 mg powder and solvent for suspension for injection PA0896/028/005

Octreotide

Novartis Ireland Limited

Marketed

Sandostatin LAR 30 mg powder and solvent for suspension for injection PA0896/028/006

Octreotide

Novartis Ireland Limited

Marketed

Scemblix 100 mg film-coated tablets EU/1/22/1670/006-007

Asciminib hydrochloride

Novartis Europharm Limited

—

Scemblix 20 mg film-coated tablets EU/1/22/1670/001-002

Asciminib hydrochloride

Novartis Europharm Limited

—

Scemblix 40 mg film-coated tablets EU/1/22/1670/003-004

Asciminib hydrochloride

Novartis Europharm Limited

—

Seebri Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/788/001-006

Glycopyrronium bromide

Novartis Europharm Limited

—

SIMBRINZA 10 mg/mL + 2 mg/mL eye drops, suspension EU/1/14/933/001-002

Brinzolamide, Brimonidine tartrate

Novartis Europharm Limited

—

Simulect 10 mg powder and solvent for solution for injection or infusion EU/1/98/084/002

Basiliximab

Novartis Europharm Limited

—

Simulect 20 mg powder and solvent for solution for injection or infusion EU/1/98/084/001

Basiliximab

Novartis Europharm Limited

—

Spexotras 0.05 mg/ml powder for oral solution EU/1/23/1781/001

Trametinib dimethyl sulfoxide

Novartis Europharm Limited

—

Tabrecta 150 mg film-coated tablets EU/1/22/1650/001-002

Capmatinib dihydrochloride monohydrate

Novartis Europharm Limited

—

Tabrecta 200 mg film-coated tablets EU/1/22/1650/003-004

Capmatinib dihydrochloride monohydrate

Novartis Europharm Limited

—

Tafinlar 50 mg hard capsules EU/1/13/865/001-002

Dabrafenib

Novartis Europharm Limited

—

Tafinlar 75 mg hard capsules EU/1/13/865/003-004

Dabrafenib

Novartis Europharm Limited

—

Tasigna 150 mg Capsule, hard EU/1/07/422/005-006

Nilotinib

Novartis Europharm Limited

—

Tasigna 200 mg Capsule, hard EU/1/07/422/001-004

Nilotinib

Novartis Europharm Limited

—

Tasigna 50 mg Capsule, hard EU/1/07/422/015

Nilotinib

Novartis Europharm Limited

—

Tegretol 100mg Tablets PA0896/030/002

Carbamazepine

Novartis Ireland Limited

Marketed

Tegretol 100mg/5ml Oral Suspension PA0896/030/001

Carbamazepine

Novartis Ireland Limited

Marketed

Tegretol 200mg Tablets PA0896/030/003

Carbamazepine

Novartis Ireland Limited

Marketed

Tegretol 400mg Tablets PA0896/030/004

Carbamazepine

Novartis Ireland Limited

Marketed

Tegretol SR 200mg prolonged release tablets PA0896/030/005

Carbamazepine

Novartis Ireland Limited

Marketed

Tegretol SR 400mg prolonged release tablets PA0896/030/006

Carbamazepine

Novartis Ireland Limited

Marketed

Tovanor Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/790/001-006

Glycopyrronium bromide

Novartis Europharm Limited

—

Travatan 40 micrograms/mL eye drops, solution EU/1/01/199/001

Travoprost

Novartis Europharm Limited

—

Travatan 40 micrograms/mL eye drops, solution EU/1/01/199/002

Travoprost

Novartis Europharm Limited

—

Trileptal 150 mg Film-coated tablets PA0896/033/001

Oxcarbazepine

Novartis Ireland Limited

Marketed

Trileptal 300 mg Film-coated tablets PA0896/033/002

Oxcarbazepine

Novartis Ireland Limited

Marketed

Trileptal 60 mg/ml Oral Suspension PA0896/033/004

Oxcarbazepine

Novartis Ireland Limited

Marketed

Trileptal 600 mg Film-coated tablets PA0896/033/003

Oxcarbazepine

Novartis Ireland Limited

Marketed

Tyverb 250 mg film-coated tablets EU/1/07/440/1-2

Lapatinib ditosylate monohydrate

Novartis Europharm Limited

—

Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/13/862/001-006

Indacaterol maleate, Glycopyrronium bromide

Novartis Europharm Limited

—

Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/14/917/001-006

Indacaterol maleate, Glycopyrronium bromide

Novartis Europharm Limited

—

Voltarol 50 mg Gastro-Resistant Tablets PA0896/034/001

Diclofenac sodium

Novartis Ireland Limited

Marketed

Voltarol Retard 100 mg Film-coated Prolonged Release Tablets PA0896/034/002

Diclofenac sodium

Novartis Ireland Limited

Marketed

Voltarol Retard 75 mg Film-coated Prolonged-release Tablets PA0896/034/003

Diclofenac sodium

Novartis Ireland Limited

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 29 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.